"We see more companies.looking at natural ways to improve animal feed, food nutrition and preservation"

What have been the main growth drivers for Tex Biosciences in the last financial year? And how much increment in average turnover has the company seen during this period?

- Shivani Thakar

Animal Feed and Contract Manufacturing have been the main growth drives for Tex Biosciences in the last financial year. We grew at 7.6 per cent to achieve a turnover of Rs 71.08 crore in 2023-24.

What infrastructure and strategies do you have in place to boost the industry developments and partnerships for this year and the coming years?

Tex Biosciences undertook a Rs 32 crore ($4 million) expansion programme to increase production capacities and improve capabilities. The expansion programme began in January 2021 and was completed by February 2024. The company added to its facilities multiple large-scale fermenters and downstream processing equipment. We also created product and market specific blenders and packing units to service our contract manufacturing customers. Our strategy is to have a strong and large manufacturing capacity to be able to effectively service the industrial biotech market and embark on more contract manufacturing projects.

In which segment do you see promising supply requirements that will shape the company's growth trajectory in the coming years? How do you strategise to stay on top of disruptions in the global supply chain?